PitchSend

Nuvectis Pharma Investor Presentation Deck

Financial and NVCT Stock Highlights Resources to support operations into 1H2025 Ticker IPO Cash NuvectisPharma, Inc. Financials NVCT February 2022 $24.6M as of 06/30/2023 Insider Ownership Founders and >5% holders Research Coverage XH.C.WAINWRIGHT&CO. LADEN BURG THAL MANN ESTABLISHED 1876 T ROTH MKM 66% Joe Pantginis Aydin Huseynov Jonathan Aschoff 21

View entire presentation